The Helmholtz Institute for Translational AngioCardioScience (HI-TAC) is a branch of the Max Delbrück Center on the campus of Heidelberg University. The Max Delbrück Center and the Mannheim and Heidelberg Medical Faculties of the University of Heidelberg jointly founded HI-TAC. HI-TAC will develop a unique systemic approach in the emerging field of cadiovascular communication biology, which is operationally designated as AngioCardioScience. Translational research at HI-TAC aims at developing a new scientific program centered on communication biology and dedicated to understanding cardiovascular functions on a systemic level during homeostasis, aging and pathological conditions. It will exploit its findings in the area of cross-organ interactions for the development of translational applications.
HI-TAC is currently in the build up phase and will provide a modern place for 100 scientists to conduct research and work in Heidelberg and Mannheim. Join our team and build up the HI-TAC together with the Max Delbrück Center and the University of Heidelberg.
The newly established Helmholtz Institute for Translational AngioCardioScience (HI-TAC) invites applications from outstanding scientists at the stage of establishing their first independent research group. Candidates should have a strong track record in cardiovascular science or closely related fields that advance our understanding of cardiovascular function and disease. Areas of interest include, but are not limited to, metabolic and mechanical signaling, immune interactions with vasculature or myocardium, and inflammatory pathways, cardiovascular malformations, development, regeneration, and ageing. The HI-TAC Group Leaders are expected to conduct pioneering independent research, secure external funding, and collaborate with top researchers and organizations in the field. The selected candidates will become part of a vibrant and collaborative community at Heidelberg University and the Max Delbrück Center.
About Us
The HI-TAC, a branch of the Max Delbrück Center at Heidelberg University, operates in close collaboration with the two Medical Faculties of Heidelberg University, located in Mannheim and Heidelberg. HI-TAC pioneers a systemic and translational approach to cardiovascular communication biology, termed Translational AngioCardioScience. Its research is dedicated to understanding cardiovascular function throughout lifespan and in disease, with a focus on how vascular and cardiac cells interact with each other and other organ systems to maintain homeostasis or cause disease. The ultimate goal of HI-TAC research is to advance early disease detection, prevention, targeted intervention and long-term remission.
As a newly established and evolving institute, HI-TAC offers group leaders a unique opportunity to help shape its scientific vision and foster an interdisciplinary culture. We invite you to become part of this dynamic and growing community at the forefront of AngioCardioScience.
We offer funding for an initial 5-year period, with a 4-year extension based on a positive evaluation by the MDC´s scientific advisory board (SAB). The package includes a competitive salary
and an attractive start-up package, covering personnel, consumables, and an investment budget to establish your HI-TAC group. The successful candidate will receive generous funding for the full duration of their appointment to establish and maintain an independent research group, with resources tailored to support their scientific focus and foster long-term development and success.
As part of HI-TAC's faculty, you will be able to choose a mentor from senior faculty at Heidelberg University and the Max Delbrück Center.
You also benefit from:
Do you want to load external content supplied by Youtube?
Excellence in science and innovation depends on a diverse, inclusive, and respectful environment. At the Max Delbrück Center, we are committed to creating such a space — one where individuals from all backgrounds can grow scientifically, professionally, and personally. As a values-driven research institute, we recognize that diversity of thought, experience, and identity is essential to our mission: advancing biomedical research to transform tomorrow's medicine. We foster a culture of curiosity, creativity, collaboration, and shared responsibility for equity and openness. We welcome applications from individuals of all genders, cultures, backgrounds, and life experiences, especially those who bring new perspectives and a collaborative spirit to our international team. Applicants are considered based on qualifications and experience, free from discrimination. We particularly welcome applications from individuals with disabilities and will ensure appropriate support is provided.
#J-18808-Ljbffr